Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection

JAMA ◽

10.1001/jama.2021.24939 ◽

2022 ◽

Author(s):

Meagan P. O’Brien ◽

Eduardo Forleo-Neto ◽

Neena Sarkar ◽

Flonza Isa ◽

Peijie Hou ◽

...

Download Full-text